[(1S)-1-methyl-2-phenyl-ethyl]amine;51-64-9;(S)-alpha-Methylphenethylamine;(S)-alpha-Phenylethylamine;4-12-00-02587 (Beilstein Handbook Reference);BRN 2205872;Benzeneethanamine, alpha-methyl-, (S)-;Benzeneethanamine, alpha-methyl-, (alphaS)-;DEA No. 1100;Desamfetamina;Desamfetamina [DCIT];Dexadrine;Dexamfetamina [INN-Spanish];Dexamfetamine;Dexamfetaminum [INN-Latin];Dexamphetaminum [INN-Latin];Dexanfetamina [INN-Spanish];Dexidrine;Dextroamphetamine [USAN];EINECS 200-112-1;HSDB 3055;NSC 73713;Phenethylamine, alpha-methyl-, (+)-;Phenethylamine, alpha-methyl-, d-;alpha-Methylphenethylamine, d-form;d-1-Phenyl-2-aminopropan [German];d-alpha-Methylphenethylamine;PDSP1_001511;PDSP2_001495;Sympamin;D03740;Dexamfetamine (INN);Dextroamphetamine (USAN);C07884;Dextroamphetamine;(2S)-1-phenylpropan-2-amine;(S)-alpha-methylbenzeneethanamine;(alphaS)-alpha-methylbenzeneethanamine;CHEBI:4469;(S)-1-Phenyl-2-propanamine;Benzeneethanamine, alpha-methyl-, (aS)- (9CI);D-(+)-Amphetamine;Phenethylamine, alpha-methyl-, (+)- (8CI);(+)-(S)-Amphetamine;(+)-Phenaminum;(+)-alpha-Methylphenethylamine;(+)-alpha-Methylphenylethylamine;(2S)-(+)-Amphetamine;(S)-(+)-beta-Phenylisopropylamine;(S)-1-Phenyl-2-aminopropane;(S)-1-Phenyl-2-propylamine